Humana HUM
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Humana (HUM) Business Model and Operations Summary
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Key Insights
Humana (HUM) Core Market Data and Business Metrics
Latest Closing Price
$264.74Market Cap
$31.89 BillionPrice-Earnings Ratio
26.53Total Outstanding Shares
120.69 Million SharesTotal Employees
65,680Dividend
$0.89 Per Share QuarterlyIPO Date
May 18, 1971SIC Description
Hospital & Medical Service PlansPrimary Exchange
New York Stock ExchangeHeadquarters
500 W Main St, Louisville, KY, 40202
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow | $-2.47 Billion |
| Net Cash Flow From Financing Activities | $-2.49 Billion |
| Net Cash Flow From Operating Activities | $2.97 Billion |
| Net Cash Flow From Financing Activities, Continuing | $-2.49 Billion |
| Net Cash Flow, Continuing | $-2.47 Billion |
| Net Cash Flow From Operating Activities, Continuing | $2.97 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit, Current | $605 Million |
| Income/Loss From Equity Method Investments | $-94 Million |
| Revenues | $117.76 Billion |
| Net Income/Loss Available To Common Stockholders, Basic | $1.21 Billion |
| Diluted Earnings Per Share | $9.98 |
| Net Income/Loss | $1.21 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss Attributable To Parent | $-68 Million |
| Comprehensive Income/Loss | $1.14 Billion |
| Comprehensive Income/Loss Attributable To Parent | $1.14 Billion |
| Other Comprehensive Income/Loss | $-68 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Noncontrolling Interest | $70 Million |
| Accounts Receivable | $2.70 Billion |
| Noncurrent Liabilities | $13.10 Billion |
| Intangible Assets | $1.44 Billion |
| Noncurrent Assets | $16.66 Billion |
| Other Current Assets | $27.11 Billion |
Historical Dividends
Current dividend: $0.89 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 20, 2025 | Apr 25, 2025 | Mar 28, 2025 | $0.885 | Quarterly |
| Oct 24, 2024 | Jan 31, 2025 | Dec 31, 2024 | $0.885 | Quarterly |
| Aug 15, 2024 | Oct 25, 2024 | Sep 30, 2024 | $0.885 | Quarterly |
| Apr 18, 2024 | Jul 26, 2024 | Jun 28, 2024 | $0.885 | Quarterly |
| Feb 15, 2024 | Apr 26, 2024 | Mar 29, 2024 | $0.885 | Quarterly |
| Oct 31, 2023 | Jan 26, 2024 | Dec 29, 2023 | $0.885 | Quarterly |